288 related articles for article (PubMed ID: 20952255)
1. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
Wheeler CM
Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
[No Abstract] [Full Text] [Related]
2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
3. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
[TBL] [Abstract][Full Text] [Related]
4. Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.
Samarawickrema NA; Tabrizi SN; Hewavisenthi J; Leong T; Garland SM
Int J Gynaecol Obstet; 2011 Nov; 115(2):180-2. PubMed ID: 21872246
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.
Alsbeih G; Ahmed R; Al-Harbi N; Venturina LA; Tulbah A; Balaraj K
Gynecol Oncol; 2011 Jun; 121(3):522-6. PubMed ID: 21353296
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
8. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
Tay K; Tay SK
Asia Pac J Clin Oncol; 2011 Jun; 7(2):154-9. PubMed ID: 21585695
[TBL] [Abstract][Full Text] [Related]
9. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
10. HPV and cervical cancer in the 2007 report.
WHO/ICO Information Centre on HPV and Cervical Cancer
Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
[No Abstract] [Full Text] [Related]
11. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
12. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
13. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
[TBL] [Abstract][Full Text] [Related]
14. Prevention strategies of cervical cancer in the HPV vaccine era.
Bosch X; Harper D
Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
[No Abstract] [Full Text] [Related]
15. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
17. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype distributions inform screening and vaccination policy.
Pinkowish MD
CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
[No Abstract] [Full Text] [Related]
19. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
20. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
Zhao Z; Wang L; Ma B
Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]